###begin article-title 0
###xml 54 60 <span type="species:ncbi:10090">murine</span>
###xml 170 175 <span type="species:ncbi:10090">mouse</span>
###xml 177 180 <span type="species:ncbi:10090">SAM</span>
Molecular cloning and nucleotide sequence of cDNA for murine senile amyloid protein: nucleotide substitutions found in apolipoprotein A-II cDNA of senescence accelerated mouse (SAM).
###end article-title 0
###begin p 1
###xml 25 31 <span type="species:ncbi:10090">murine</span>
###xml 128 131 <span type="species:ncbi:10090">SAM</span>
###xml 160 163 <span type="species:ncbi:10090">SAM</span>
###xml 420 423 <span type="species:ncbi:10090">SAM</span>
###xml 432 435 <span type="species:ncbi:10090">SAM</span>
###xml 479 485 <span type="species:ncbi:10090">murine</span>
###xml 591 594 <span type="species:ncbi:10090">SAM</span>
###xml 601 604 <span type="species:ncbi:10090">SAM</span>
###xml 636 640 <span type="species:ncbi:10090">mice</span>
###xml 701 704 <span type="species:ncbi:10090">SAM</span>
cDNA clones encoding the murine senile amyloid protein (ASSAM) have been isolated from animal models of accelerated senescence (SAM-P/1) and from normal aging (SAM-R/1). Immunochemical and protein sequence studies revealed that apolipoprotein (apo) A-II is a serum precursor of ASSAM. A 17-base synthetic oligonucleotide based on residues 39-44 of ASSAM was used as a hybridization probe for screening newly constructed SAM-P/1 and SAM-R/1 liver cDNA libraries. The structure of murine apo A-II cDNA is of interest because of the amino acid substitution found in ASSAM and serum apo A-II of SAM-P; in SAM-R or other random bred slc:ICR mice, amino acid residue 5 of mature apo A-II is proline but, in SAM-P, this amino acid is changed to glutamine. This amino acid replacement is caused by two nucleotide substitutions (CCA for proline codon to CAG for glutamine codon). The third base mutation may not be relevant to the substitution of amino acid. Attention is directed to the relation of this amino acid substitution to the specific deposition of apo A-II, as a tissue amyloid fibril.
###end p 1
###begin title 2
Images
###end title 2

